Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant

Autor: Inès Ferrandiz, Olivier Cointault, Nassim Kamar, Laure Esposito, Anne Laure Hebral, Arnaud Del Bello, Valérie Hage, Julie Belliere

Publikováno v: Experimental and Clinical Transplantation. 17:313-319

Objectives Antibody-mediated rejection is a main cause of long-term kidney allograft loss. Nonad-herence and tacrolimus intrapatient variability have been identified as risk factors for developing de novo donor-specific antibodies. Tacrolimus, given

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041775903db2a3c853a52f7c32794548
https://doi.org/10.6002/ect.2018.0043

Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-LA Antibodies

Autor: Nicolas Congy-Jolivet, Bénédicte Debiol, Gaëlle Dörr, Katy Trébern-Launay, Lionel Rostaing, L. Esposito, David Milongo, A. Del Bello, Inès Ferrandiz, Nassim Kamar

Publikováno v: American Journal of Transplantation
American Journal of Transplantation, Wiley, 2016, 16 (9), pp.2661-2669. ⟨10.1111/ajt.13795⟩
American Journal of Transplantation, 2016, 16 (9), pp.2661-2669. ⟨10.1111/ajt.13795⟩

International audience; Little is known about the impact of posttransplant blood transfusion on the sensitization of anti-HLA antibodies and the formation of donor-specific antibodies (DSAs). The aims of our study were to determine the 1-year incide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb163a5870b2cbd3e66075e9e3ab1981
https://doi.org/10.1111/ajt.13795